Clinical Trials

Search for trials
Clinical Trial
  • Status: Not yet recruiting
  • Intervention Type: Drug
  • Participants: 60
  • Start Date: February 2, 2021
Final Height in Patients With Congenital Hypothyroidism Diagnosed by Neonatal Screening
Clinical Trial
  • Status: Not yet recruiting
  • Participants: 60
  • Start Date: February 1, 2021
Congenital Hypothyroidism in Children With Eutopic Gland or Thyroid Hemiagenesis: Predictive Factors for Transient vs Permanent Hypothyroidism.
Search for trials
Clinical Trial
  • Status: Not yet recruiting
  • Phase: N/A
  • Intervention Type: Other
  • Participants: 6
  • Start Date: October 20, 2020
Genetic Analysis Coupled to Application of Isotopic Techniques to the Study of Mauriac Syndrome
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 2
  • Intervention Type: Biological
  • Participants: 20
  • Start Date: October 10, 2020
A Randomized, Controlled, Open-label Clinical Trial With an Open-label Extension to Investigate the Safety of Vosoritide in Infants and Young Children With Achondroplasia at Risk of Requiring Cervicomedullary Decompression Surgery
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 2
  • Intervention Type: Drug
  • Participants: 80
  • Start Date: October 7, 2020
A Multicenter, 6-Month, Randomized, Open-Label, Active Control, Parallel Arm, Phase 2b Study of Daily Oral LUM-201 in Naïve to Treatment, Prepubertal Children With Growth Hormone Deficiency (GHD)
Clinical Trial
  • Status: Enrolling by invitation
  • Phase: Phase 2
  • Intervention Type: Drug
  • Participants: 60
  • Start Date: June 24, 2020
ACcomplisH: A Phase 2, Multicenter, Double-blind, Randomized, Placebo-controlled, Dose Escalation Trial Evaluating Safety, Efficacy, and Pharmacokinetics of Subcutaneous Doses of TransCon CNP Administered Once Weekly for 12 Months in Prepubertal Children With Achondroplasia
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 2
  • Intervention Type: Drug
  • Participants: 60
  • Start Date: March 10, 2020
Phase 2, Open-Label, Dose-Escalation and Dose-Expansion Study of Infigratinib, an FGFR 1-3-Selective Tyrosine Kinase Inhibitor, in Children With Achondroplasia: PROPEL 2
Clinical Trial
  • Status: Recruiting
  • Intervention Type: Dietary Supplement
  • Participants: 1000
  • Start Date: January 10, 2020
Observational Study on the Impact of Iodine Supplementation on Maternal and Child's Thyroid Hormone Homeostasis and on the Child's Psychomotor Development, in the Portuguese Minho Region (IodineMinho)
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 4
  • Intervention Type: Drug
  • Participants: 112
  • Start Date: November 30, 2019
Effect of Height Versus Height and Weight Based Intrathecal Bupivacaine Dose on Maternal Haemodynamics for Elective Caesarean Section in Short Stature Patients: A Randomized Trial
Clinical Trial
  • Status: Recruiting
  • Participants: 200
  • Start Date: August 12, 2019
Prospective Clinical Assessment Study in Children With Achondroplasia: The PROPEL Trial
Clinical Trial
  • Status: Recruiting
  • Intervention Type: Drug
  • Participants: 45
  • Start Date: July 22, 2019
Recombinant Human Growth Hormone (GH): Effects on Metabolic Profile, Body Composition and Skeletal Muscle Strength and Function in Pre-pubertal Short Boys With and Without GH Deficiency
Clinical Trial
  • Status: Enrolling by invitation
  • Intervention Type: Drug
  • Participants: 750
  • Start Date: June 21, 2019
A Non-interventional, Prospective Study in Germany to Investigate the Influence of Adherence to Growth Hormone Therapy (GHT) With Norditropin® on Near Final Height in a Patient Population With Isolated Growth Hormone Deficiency (GHD) and Born Small for Gestational Age (SGA)
Showing 1-12 of 25